Modern Validation - Case Studies

23-24 February 2017, Hamburg, Germany

Course No. 15521

header-image

Speakers

Dr Marc Egen, Boehringer Ingelheim, Germany

Walid El Azab, STERIS Corperation, Belgium

Timur Güvercinci, Merck Group, Germany

Peter Kralinger, Carrymed Pharma & Transport, GmbH, Austria

Dr Jean-Denis Mallet, NNE Pharmaplan, France

Gert Mølgaard, Head of ECA´s Validation Group, Denmark

Objectives

The revised Annex 15 is valid since October 2015. With the revision new requirements have been implemented regarding:

  • Validation Master Plan
  • Qualification
  • Process Validation
  • Cleaning Validation
  • Transport Verification
  • Packaging Validation
In 6 Case Studies will be explained how companies implement the new Annex 15 requirements. Also the differences to the FDA Process Validation Guidance will be discussed.

Background

Since 2001 the Annex 15 was state of the art for Validation and Qualification. In the meantime, ICH Q 8-11 has been published. The FDA has implemented most of these ICH guidelines and introduced a Validation Process Life Cycle in its Process Validation Guidance from 2011. The EMA has published a revision of its Note for Guidance on Process Validation to implement this new aspects too. This is also the reason why the Annex 15 has been revised. The Annex 15 revision is valid since October 2015.

Target Group

Everyone who may be influenced by the Annex 15 revision.

Programme

History of Validation with regard to Annex 15

  • Validation in the 70´s – focus on sterile production
  • FIP Validation Guideline
  • PIC Validation Conference 1982
  • The mother guideline of Validation: FDA´s Process Validation Guideline 1987
  • PIC/PH 1/96
  • Annex 15 2001
  • EMEA Note for Guidance on Process Validation
  • FDA Guidance CPG 7132.c08
  • WHO Process Validation Guideline
  • FDA Process Validation: Guidance for Industry
  • EMA Guideline on Process Validation
  • Annex 15 Revision
  • WHO revision of Validation Guidelines
  • EMA: Biotech Process Validation Guideline
Annex 15 vs FDA Process Validiation Guidance – Similarities and Differences
  • History of Annex 15 and FDA Process Validation Guidance
  • Role of EMA Process Validation Guideline vs. Annex 15
  • Similarities Annex 15 vs FDA Process Validation Guidance
  • Differences Annex 15 and FDA Process Validation Guidance
Lean Qualification meeting Annex 15 requirements – is this possible?
  • Annex 15´s 8-stage Qualification
  • ASTM 2500 as an alternative
  • Case Study Qualification regarding ASTM 2500
Continuous Process Verification –ICH Q8 as starting point for Process Validation
  • ICH Q 8
  • Continuous Process Verification
  • Case Study: Design Space, PAT Application, Design Space Verification, Process Governance during DP lifecycle
Ongoing Process Verification – how to get there
  • Ongoing Process Verification vs. Continued Process Verification
  • Case Study
  • Outlook
Transport Verification
  • Qualification, Validation, Verification
  • Requirements of Annex 15
  • Guideline Good Transportation Practice
  • Case Study
Packaging Validation
  • Requirements of Annex 15
  • Qualification of packaging lines
  • The valiation of primary vs secondary packaging processes
  • Case Study
Cleaning Validation
  • Requirements of Annex 15
  • EMA guidance on PDE: PDE and ADE similarities and difference, Setting cleaning limit – risk assessment approach

stop

This course is part of the GMP Certification Programme "ECA Certified Validation Manager" Learn more

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025